smart. precise. brilliant.
Eyenovia is a clinical stage, ophthalmic biopharmaceutical company transforming the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. Eyenovia’s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics.
At Eyenovia, we believe that when it comes to your eyes, smaller is better.
Eyenovia: Changing the 100-year old
eyedropper paradigm. Microdrops reduce conventional
overdosing by more than 80%!
Eyenovia: High precision targeted
microdroplet therapy …precEYEsely.
Beat the blink! Eyenovia microdrops are delivered
within 80 milliseconds…Faster than the blink reflex!
“Smart eye care...means better eye care! Dynamic, real time monitoring and compliance data for you and your doctor!
Watch a brief video about our technology
TEST YOUR EYE Q
Eyenovia’s development pipeline includes three late stage NDA-enabling programs in key ophthalmic indications
Eyenovia leadership has deep ophthalmic and pharmaceutical development expertise at the management
and board level, with a strong advisory panel of clinical experts and scientists.
SEAN IANCHULEV, MD MPH
CEO and President
FRED ESHELMAN, PHD
Chairman of the Board
CURT LABELLE, MD MBA
ERNEST MARIO, PHD
Lee Kramm, MD
VP of Regulatory Affairs
Dr. Lee Kramm is a board certified Ophthalmologist with a Masters' degree in Biomedical Engineering. He earned his graduate degree from the Tulane University School of Engineering and his medical degree from the University of Miami School of Medicine. Following medical school he received general and surgical training in Ophthalmology from the Rocky Mountain Lions Eye Institute at the University of Colorado in Denver. Dr. Kramm served for five years as a medical officer and scientific reviewer in the Division of Ophthalmic, Neurological and ENT Devices in the Center for Devices and Radiological Health, FDA. In his position as a medical officer at FDA, Dr. Kramm reviewed a variety of ophthalmic devices and served on several internal FDA working groups whose goal was to improve and bring consistency to premarket regulation and clinical evaluation. During his tenure at FDA, Dr. Kramm reviewed pre-IDEs, IDEs, PMAs, 510(k)s, Humanitarian Use Designations (HUD), Humanitarian Device Exemptions (HDE), Class I/II device recalls, combination products and requests for designation (RFD).
VP of Clinical Operations
Ginger Clasby has worked in the field of regulated medical products during most of her career. Most recently she served as Vice President, Clinical & Regulatory Affairs/Quality Assurance at Transcend Medical, an early-stage, venture-backed company developing novel products for management of glaucoma, which was acquired by Alcon. In that position, she was responsible for overseeing clinical operations and regulatory processes for the company’s trials in the US, Europe and Latin America, as well as worldwide regulatory affairs, quality assurance and compliance activities. Previously, Ginger worked with ophthalmic device companies American Medical Optics and Optical Radiation Corporation in various roles in the areas of Clinical Affairs, Manufacturing Operations and Marketing/Sales. She was also a pivotal executive with Promedica International, a contract research organization, where she worked closely with clients to establish the company as a respected provider of clinical research services within the ophthalmic and medical device market sectors. She holds the MS degree in Industrial Engineering from Arizona State University and BS degrees in Mathematics & Physics from Guilford College. She serves on the University of California-Irvine Extension Life Science Advisory Committee.
Contact us for more information
Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.
New York 501 Fifth Avenue, Suite 1404 New York NY 10017